Investors eager to do some heavy lifting for Malin shares
Drug and biotech fund Malin is thought to have buyers waiting in the wings to snap up a huge block of shares in the company held by embattled fund manager Neil Woodford.
It is understood that institutional and individual investors are keen to lift the overhang on Malin’s share price caused by Woodford’s 23 per cent holding in the company by acquiring the stock. Approaches to him are thought to have been made.
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply